| abstract |
The present invention provides a heterocyclic compound having a HDAC inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound. n The present invention relates to a compound represented by the formula (I): n n n n n n n n n n wherein each symbol is as described in the description, or a salt thereof. |